Back to results
US 2024/0199627 A1Published application
Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7h-imidazo[1,5-a]pyrazin-8-one
AssigneeCardurion Pharmaceuticals, LLC
InventorsSuzanne BUTTAR, Mateusz PITAK, Adam Ross PATTERSON, Samuel Alexander STRATFORD, Ioana SOVAGO, Jun XU, Peng ZHOU, Haojuan WEI, Kuangchu DAI
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to crystalline polymorph forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one.
Claims20
A monohydrate crystalline form of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one
Dependencies are inferred from the claim text.